Interestana
Home/News/Pet Longevity Treatments Mirror Human Trends
Bloomberg Markets3 min read

By Interestana AI Editorial — AI-drafted, human-overseen. How we report

Pet Longevity Treatments Mirror Human Trends

American pet owners are increasingly applying human longevity treatments to their canine companions, mirroring trends seen in human health and wellness. This burgeoning movement involves the experimental use of various interventions, including dietary supplements, red light therapy, and pharmaceuticals such as rapamycin. These treatments are being explored by pet owners seeking to extend the lifespan and improve the healthspan of their dogs, drawing parallels to the growing interest in anti-aging therapies for humans.

Veterinarians, however, are urging caution regarding these unproven treatments. While acknowledging the strong bond between owners and their pets, and the desire to provide the best possible care, the veterinary community emphasizes the need for scientifically validated approaches. Many of these longevity interventions for pets lack robust clinical trials and long-term safety data, raising concerns about potential side effects and efficacy. The American Veterinary Medical Association (AVMA) and other professional bodies often recommend treatments with established scientific backing.

The trend reflects a broader shift in pet care, where pets are increasingly viewed as integral family members, leading owners to invest more in their well-being. This sentiment is underscored by the projected growth in US pet spending, which is anticipated to reach $165 billion in 2026, according to Bloomberg News National Health Care Reporter Anna Edney. This significant financial commitment highlights the depth of the human-animal bond and the willingness of owners to explore novel avenues for their pets' health.

Rapamycin, a drug originally developed as an immunosuppressant and later studied for its anti-aging properties in humans and other animals, is one of the more discussed pharmaceuticals in this context. Its use in pets is largely off-label and experimental, with ongoing research into its potential benefits and risks for canine health. Similarly, supplements and red light therapy, while having some established applications in human health, are being adopted for pets without extensive peer-reviewed studies specific to canine physiology and longevity. The veterinary profession continues to advocate for evidence-based medicine, encouraging owners to consult with their veterinarians before initiating any new treatment regimens for their pets, particularly those that are experimental or not widely recognized within the veterinary community.

Original source — read the full reporting at the publisher:

Read on Bloomberg Markets

Get the weekly AI digest

AI news + new model releases, weekly. Drafted by our agents, reviewed by humans.

Read next